 | Up a level |
Jump to: Journal Article
Number of items: 1.
Journal Article
Cora, N. S., Sergio, B., Ugo, D. G., Giuseppe, P., Simon, C., Wassim, A., Angel, A. A. Jose, Gedske, D., Karim, F., Eliahu, G., Axel, H., Florence, J., Ray, M., Axel, S. M., Maria, P. Josep, Brieuc, S., Srikala, S., Tony, G., Charles, J. R. and Howard, I. S. (2017). The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD). Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041